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Background: The purpose of this study was to assess the relationship of smoking duration 
with respiratory symptoms and history of chronic obstructive pulmonary disease (COPD) in 
the South Carolina Behavioral Risk Factor Surveillance System survey in 2012.
Methods: Data from 4,135 adults aged $45 years with a smoking history were analyzed using 
multivariable logistic regression that accounted for sex, age, race/ethnicity, education, and cur-
rent smoking status, as well as the complex sampling design.
Results: The distribution of smoking duration ranged from 19.2% (1–9 years) to 36.2% 
($30 years). Among 1,454 respondents who had smoked for $30 years, 58.3% were cur-
rent smokers, 25.0% had frequent productive cough, 11.2% had frequent shortness of breath, 
16.7% strongly agreed that shortness of breath affected physical activity, and 25.6% had been 
diagnosed with COPD. Prevalence of COPD and each respiratory symptom was lower among 
former smokers who quit $10 years earlier compared with current smokers. Smoking duration 
had a linear relationship with COPD (P,0.001) and all three respiratory symptoms (P,0.001) 
after adjusting for smoking status and other covariates. While COPD prevalence increased 
with prolonged smoking duration in both men and women, women had a higher age-adjusted 
prevalence of COPD in the 1–9 years, 20–29 years, and $30 years duration periods.
Conclusion: These state population data confirm that prolonged tobacco use is associated with 
respiratory symptoms and COPD after controlling for current smoking behavior.
Keywords: tobacco use, chronic obstructive pulmonary disease, respiratory symptoms, 
population-based study
Introduction
Chronic obstructive pulmonary disease (COPD), which includes both chronic bronchitis 
and emphysema, is characterized by airflow obstruction, and may be accompanied 
by airway hyperreactivity, chronic cough, sputum production, shortness of breath 
(SOB), wheezing, exercise intolerance, and poor quality of life.1,2 For 50 years, the 
biologic plausibility for a link between cigarette smoking and adverse respiratory 
system outcomes has been supported by epidemiologic and clinical evidence.3,4 
Risks of lung cancer, COPD, and other respiratory conditions such as asthma are 
increased in smokers, particularly among those with extensive exposure histories.4 
Sex also appears to affect the risk of adverse respiratory effects from smoking. 
Most studies show that smoking has greater adverse effects on respiratory function 
among women than among men.5–11 However, other studies have not been consistent 
with that finding.12–15 The sex difference in many previous studies of international 
populations or small study populations was observed when using self-reported 
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pack-years (product of intensity and duration) of smoking 
as a measure of tobacco exposure.6–8,11–13,15
There has been little information about the relation-
ship between respiratory symptoms and number of years 
(duration) of tobacco use, particularly in a population rep-
resentative of a US state. This is also true with regard to the 
relationship between duration of tobacco use, respiratory 
symptoms, and sex. Pack-year history requires the use of 
two survey questions, whereas years of tobacco use can be 
estimated by a single question. South Carolina is a US state 
with a high prevalence of current smoking (21.0% in 2010) 
and COPD (7.7% in 2011), and a high mortality rate from 
COPD (68.6 per 100,000 in 2010).16,17 The South Carolina 
Behavioral Risk Factor Surveillance System (BRFSS), an 
annual health survey, included state-added questions regard-
ing years of tobacco use and respiratory symptoms in 2012 
and provided an opportunity to assess the association of 
prolonged tobacco use with respiratory symptoms and COPD 
in a contemporary state population of adult respondents with 
a smoking history.
Materials and methods
The BRFSS is an annual random-digital-dialed telephone 
survey conducted by state health departments in collabora-
tion with the Centers for Disease Control and Prevention 
(CDC) in all 50 states, the District of Columbia, and US 
territories. The state-based BRFSS has collected data from 
households with landline and cellular telephones, and has 
incorporated a new sample weighting method since 2011 
(http://www.cdc.gov/brfss/annual_data/annual_2011.
htm). The BRFSS includes core questions about socio-
demographic characteristics, risk behaviors, and chronic 
diseases including COPD; optional modules (standardized 
questions provided by the CDC and chosen by a state based 
on the state’s priorities and budget); and questions added 
by the state. Questions addressing respiratory symptoms 
and years of tobacco use were added to the 2012 South 
Carolina BRFSS and were analyzed in this study. The 
2012 South Carolina BRFSS combined response rate (the 
number of respondents who completed the survey as a 
proportion of all eligible and likely eligible persons using 
standards set by the American Association of Public Opin-
ion Research Response Rate Formula #4 [http://www.aapor.
org/Standard_Definitions2.htm]) was 48.6% (http://www.
cdc.gov/brfss/annual_data/2012/pdf/SummaryDataQuality
Report2012_20130712.pdf). This study is a secondary data 
analysis, which is exempt from the need for approval of an 
institutional review board.
respiratory outcomes
A history of COPD was defined by the subject’s affirmative 
responses to the question “Has a doctor, nurse, or other health 
professional ever told you that you have chronic obstruc-
tive pulmonary disease or COPD, emphysema or chronic 
bronchitis?” The small number of persons who reported 
“don’t know/not sure” were defined as not having been 
diagnosed with COPD. Overall, 76.4% of respondents with 
self-reported COPD also reported having had a breathing 
test such as spirometry.
Respiratory symptoms were measured by three variables. 
In response to the question “How often do you cough up 
mucus or phlegm?”, we defined the presence of a frequent 
phlegm-producing cough as a response of “everyday”, or 
“most days a week” to compare with respondents with “a few 
days a month”, “only with occasional colds or chest infec-
tions”, or “never”. In response to “During the past 30 days, 
how often did you feel short of breath?”, we defined frequent 
SOB as a response of “all the time” or “most of the time” to 
compare with respondents with a response of “some of the 
time”, “a little of the time”, or “none of the time”. For the 
third question “Thinking about your physical activity dur-
ing the last 12 months, do you agree slightly or strongly, or 
disagree slightly or strongly with the following statement: 
I do less now than I used to because of my breathing prob-
lems”, we compared those who said “strongly agree” with 
respondents who gave the other response options. These 
three respiratory symptom questions were selected from a 
validated study with a positive predictive value of 56.8% and 
a negative predictive value of 86.4%, which is considered 
to be a highly reliable questionnaire when compared with 
spirometry measures.18
smoking behaviors
For the analyses presented in this report, we identified respon-
dents with a history of cigarette smoking by an affirmative 
response to the tobacco use question, “Have you smoked 
at least 100 cigarettes in your entire life?” Years (duration) 
of tobacco use were further determined from the question 
“Over your lifetime, how many years have you smoked 
tobacco products?” and were divided into four duration 
groups (1–9 years, 10–19 years, 20–29 years, and $30 years). 
Persons who responded “not at all” to the third tobacco use 
question, “Do you now smoke cigarettes, every day, some 
days, or not at all?” were defined as former smokers and the 
remainder were defined as current smokers. Former smok-
ers were also asked to identify how long it had been since 
they last smoked a cigarette, even one or two puffs. Former 
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smokers were then defined either by having quit smoking 
for $10 years (72.7%) or by all other responses (26.8% 
reported quit durations ,10 years and 0.5% failed to provide 
information on quit duration).
We restricted this study to adults aged $45 years because 
there was a low prevalence of COPD (3.7%) and smok-
ing $30 years (1.9%) among respondents aged 18–44 years, 
resulting in unstable sample sizes in that age group. In the 
survey population of 9,386 respondents aged $45 years, 
46.2% had never smoked, 33.8% were former smokers, and 
18.3% were current smokers. Leffondre et al has observed 
that inclusion of respondents who have never smoked may 
produce overestimations of the effects of smoking duration 
when that group is assigned a value of zero smoking years 
and is set as the referent group in an analysis;19 therefore, 
we restricted this study to former and current smokers 
(4,553 respondents) aged $45 years. Data from 4,135 
(90.8%) respondents who provided information on smoking 
duration, respiratory symptoms, and history of COPD were 
analyzed in this study after those who had missing informa-
tion were excluded.
statistical analysis
We examined the distributions of selected characteristics 
among study respondents by smoking duration. We estimated 
95% confidence intervals (CIs) for the percentages and used 
two-sided t-tests to compare characteristics between groups 
defined by smoking duration and to assess linear trends in 
characteristics by smoking duration. The distribution of 
smoking duration by current smoking status (current smokers, 
former smokers who had quit for $10 years, and other former 
smokers) was also examined. The age-adjusted prevalence 
and 95% CI of respiratory symptoms and COPD by smoking 
duration and current smoking status were obtained from sepa-
rate logistic regression models that included age (45–59 years, 
60–69 years, and $70 years) as the covariate. Finally, we 
assessed the adjusted prevalence ratios and 95% CIs for 
the likelihood of having respiratory symptoms and COPD 
associated with smoking duration using separate multivari-
able logistic regression models that included sex, age, race/
ethnicity (non-Hispanic white, non-Hispanic black, or other/
multiracial), education (less than a high school diploma, a 
high school graduate or equivalent, or at least some college), 
and current smoking status (current vs former) as covari-
ates. Prior research suggesting that women might be more 
susceptible than men to the effects of smoking prompted 
testing for an interaction between sex and smoking duration 
in separate age-adjusted logistic regression models for each 
of the four dependent variables. The only sex interaction was 
observed for COPD (P=0.085). We also assessed whether the 
relationships between smoking duration and the dependent 
variables differed by current smoking status, but failed to 
find a significant interaction for COPD (P=0.79) or for any 
of the three respiratory symptoms (P.0.42). There were also 
no significant interactions between age and sleep duration 
for any outcome (P.0.30). All analyses were conducted 
using Statistical Analysis System (SAS)-callable SUDAAN 
(Release 10.0.1, Research Triangle Institute, NC, USA) to 
account for the complex sampling design.
Results
Table 1 shows the distribution of selected characteristics 
by smoking duration among 4,135 adults aged $45 years 
with a history of smoking. The distributions of age and race/
ethnicity did not differ significantly by smoking duration. 
Respondents who had smoked for $30 years were more 
likely to be male (P,0.05), have less than a high school 
education (P,0.05), and less likely to have some college 
education (P,0.05) than persons who had smoked for 1–9 
years or 10–19 years. The proportion of the study population 
who were current smokers increased with increasing smoking 
duration (linear trend, P,0.05) such that 58.3% of those who 
had smoked for $30 years continued to be current smokers 
compared with 7.5% of those who had smoked for 1–9 years. 
The proportion of the study population comprising former 
smokers with quit durations of $10 years declined as smok-
ing duration increased (linear trend, P,0.05).
The distribution of smoking duration was 19.2% 
for 1–9 years, 21.6% for 10–19 years, 23.0% for 20–29 years, 
and 36.2% for $30 years. The increase in the proportions for 
each smoking duration was observed in men and women, all 
age groups, non-Hispanic whites, non-Hispanic blacks, and 
all education groups (data not shown). Figure 1 shows an 
inverse linear trend for smoking duration category in former 
smokers with quit durations of $10 years, while current 
smokers and other former smokers had a linear increase such 
that 60.0% of all current smokers and 43.6% of other former 
smokers had smoked for $30 years in contrast with 15.6% 
of former smokers who had quit for $10 years.
We assessed the age-adjusted prevalence of COPD and 
the three respiratory symptoms by current smoking status 
(Figure 2). Former smokers with quit durations $10 years 
reported a significantly lower age-adjusted percentage of 
frequent productive cough (10.6% vs 24.2%, respectively, 
P,0.001), frequent SOB (5.7% vs 9.9%, P=0.001), agree-
ment that SOB affects physical activity (8.8% vs 13.8%, 
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Figure 1 Distribution of years of tobacco exposure among 4,135 adults aged 
$45 years with a smoking history by current smoking status in south Carolina, 2012 
(Behavioral risk Factor surveillance system).
Figure 2 age-adjusted percentage of respiratory symptoms and COPD among 
adults aged $45 years with a smoking history by current smoking status in south 
Carolina, 2012 (Behavioral risk Factor surveillance system).
Abbreviations: COPD, chronic obstructive pulmonary disease; sOB, shortness 
of breath.
P,0.0001), and COPD (8.6% vs 22.7%, P,0.0001) 
compared with current smokers. In contrast, other former 
smokers with either no stated quit duration or quit durations 
,10 years did not differ significantly from current smokers 
in prevalence of frequent SOB, agreement that SOB affects 
physical activity, and COPD, although this former smoker 
group reported a significant lower age-adjusted percentage of 
frequent productive cough than did current smokers (11.5% 
vs 24.2%, P,0.0001).
Data in Table 2 demonstrate that the age-adjusted preva-
lence of each respiratory symptom and COPD increased with 
increasing smoking duration (linear trend, P,0.001). Among 
those who had smoked for $30 years, 25.6% reported COPD, 
25.0% had frequent productive cough, 11.2% had frequent 
Table 1 Distribution of selected characteristics among 4,135 adults aged $45 years with a smoking history by smoking duration in 
south Carolina, 2012 (Behavioral risk Factor surveillance system)
Characteristic na Smoking duration (years)
1–9
(n=799)
% (95% CI)b
10–19
(n=952)
% (95% CI)b
20–29
(n=930)
% (95% CI)b
$30
(n=1,454)
% (95% CI)b
sex
Men 1,971 46.4 (41.3–51.6) 49.4 (44.8–54.0) 59.3 (54.9–63.5) 59.2 (55.7–62.7)
Women 2,164 53.6 (48.4–58.7) 50.6 (46.0–55.2) 40.7 (36.5–45.1) 40.8 (37.3–44.3)
age (years)
45–59 1,555 49.6 (44.5–54.7) 51.3 (46.7–55.8) 52.1 (47.6–56.7) 47.2 (43.5–50.9)
60–69 1,371 33.4 (28.8–38.4) 26.1 (22.5–30.1) 25.9 (22.3–29.8) 30.7 (27.4–34.1)
$70 1,209 17.0 (13.9–20.5) 22.6 (19.3–26.3) 22.0 (18.7–25.7) 22.1 (19.6–24.9)
race/ethnicity
non-hispanic white 3,092 73.5 (68.5–78.0) 73.7 (69.3–77.7) 76.0 (71.6–79.9) 79.5 (76.2–82.5)
non-hispanic black 862 22.3 (18.3–27.0) 21.7 (18.0–25.8) 19.1 (15.7–23.1) 15.4 (12.8–18.3)
Other/multiracial 181 –c –c –c 5.1 (3.5– 7.4)
education
less than high school diploma 580 14.9 (11.1–19.8) 14.1 (10.9–18.0) 20.6 (16.7–25.2) 26.6 (23.1–30.3)
high school graduate or equivalent 1,297 26.4 (22.1–31.2) 32.6 (28.4–37.0) 36.3 (32.0–40.8) 32.1 (28.9–35.5)
at least some college 2,258 58.7 (53.4–63.8) 53.4 (48.7–57.9) 43.1 (38.8–47.6) 41.3 (37.9–44.9)
smoking status
Current smokers 1,253 7.5 (5.1–10.8) 20.6 (16.9–25.0) 35.3 (30.8–40.0) 58.3 (54.7–61.8)
Former smokers (quit $10 years) 2,157 79.8 (75.4–83.6) 65.0 (60.3–69.4) 45.5 (41.0–50.0) 20.4 (17.8–23.3)
Other former smokersd 722 12.7 (9.8–16.4) 14.4 (11.3–18.1) 19.2 (15.8–23.1) 21.3 (18.5–24.5)
Notes: aUnweighted sample size; bweighted percentage and 95% CI; cunreliable estimate due to small sample size; dother former smokers include persons who did not 
provide quit durations (n=11) as well as those with quit durations ,10 years.
Abbreviation: CI, confidence interval.
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SOB, and 16.7% strongly agreed that SOB had affected 
physical activity in the previous year. After controlling for 
age, sex, race/ethnicity, education, and current smoking sta-
tus, there remained an increased likelihood for having COPD 
and all three respiratory symptoms associated with increasing 
smoking duration (linear trend, P,0.001).
However, after restricting the analyses to the 3,495 
respondents who responded that they had not been diagnosed 
with COPD, only one respiratory symptom remained signifi-
cantly associated with smoking duration (Table 2, P,0.001). 
The age-adjusted percentage of respondents without COPD 
who reported having frequent productive cough increased 
with increasing smoking duration (linear trend, P,0.001). 
This relationship persisted even after adjustment for age, sex, 
race/ethnicity, education, and current smoking status (linear 
trend, P=0.009). However, only a modest significant associa-
tion was observed among respondents without COPD and 
with a smoking duration $30 years compared with those in 
the 1–9 year duration (prevalence ratio 1.85; 95% confidence 
interval 1.06–3.21).
There was a borderline significant sex interaction 
(P=0.085) of the relationship between smoking duration and 
prevalence of COPD (Figure 3). The age-adjusted prevalence 
increased with increasing smoking duration for both men 
and women. However, women had a significantly higher 
age-adjusted prevalence of COPD than men for a smoking 
duration of 1–9 years (10.1% vs 2.8%, P,0.001), 20–29 
years (15.3% vs 9.2%, P=0.04), and $30 years (30.9% vs 
21.9%, P,0.001) but there was no difference at 10–19 years 
(9.3% vs 8.9%, P=0.93).
Discussion
Our study is the first population-based health survey in 
many years that has assessed the relationship between 
duration of tobacco use and respiratory outcomes in adults T
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Figure 3 age-adjusted prevalence of chronic obstructive pulmonary disease among 
adults aged $45 years with a history of smoking by sex and smoking duration in 
south Carolina, 2012 (Behavioral risk Factor surveillance system).
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with a smoking history in the USA. This study provides a 
population-based perspective of the relationship between 
smoking duration, three respiratory symptoms, and COPD 
in a US state with a high prevalence of current cigarette 
smoking and COPD. These relationships in a contemporary 
population in 2012 are consistent with similar dose–response 
relationships observed in a Norwegian study (1995–1997) 
for number of pack-years of smoking and chronic bronchitis, 
breathlessness, persistent coughing, coughing with phlegm, 
and reduced lung function.7,8 We observed that the significant 
relationship between smoking duration and frequent produc-
tive cough was also present in adults without a self-reported 
diagnosis of COPD; however, the relationship between 
smoking duration, frequent SOB, and the effects of SOB on 
physical activity were not significant in adults without COPD. 
Our results also showed that smoking cessation for $10 years 
in contrast with current smoking was associated with a much 
lower prevalence of COPD and of each of the three respira-
tory symptoms. Our results are consistent with the COPD 
prevention strategy that smoking cessation improves respira-
tory function and prevents excessive decline in lung function 
in smokers with COPD as well as in smokers without chronic 
symptoms.20,21 The health benefits of smoking cessation with 
regard to the rate of decline in forced expiratory volume in 
1 second (FEV
1
) and mortality appear to be most significant 
for persons who quit before 40–50 years of age.14,22
The sex difference in the age-adjusted relationship of 
smoking duration with COPD demonstrated in this study is 
consistent with reports that women may be more susceptible 
to the detrimental effects of smoking at the 1–9 year dura-
tion than men. Women were similar to men in terms of the 
significant relationship between smoking duration and respira-
tory symptoms. Prior studies conducted in the late 1990s and 
early 2000s suggested that women smokers were particularly 
susceptible to the deleterious effects of smoking, with an aug-
mented decline in FEV
1
 compared with male smokers.6,8,9,11,20 
In addition, results from the Lung Health Study (1986–1994) 
showed that smoking cessation has a greater impact on rate of 
FEV
1 
decline in women than in men.23 However, Kohansal et 
al did not report a sex difference in the loss of lung function 
associated with continued or stopping smoking.14 Suggested 
explanations for the female–male difference in relationship 
between smoking duration and respiratory function have 
included sex variation in the prevalence of lifetime smoking, 
biologic differences such as smaller lungs and larger airways 
in women, hormonal factors that influence epithelial cell 
function, sex differences in inflammatory responses, greater 
awareness or recall of respiratory symptoms and diagnosed 
disease among women, and sex differences in the clinical 
presentation of COPD.8,20,24 A previous study suggested that 
African-American women with COPD had a greater loss of 
lung function due to cigarette smoking than other COPD 
patients.5,25 However, the current study did not have a sample 
size sufficient to assess that relationship in groups defined by 
race, sex, and smoking duration.
As would be expected, current smokers were more likely 
to have a frequent productive cough. The “smoker’s cough” 
is consistent with chronic bronchitis, and is primarily due 
to excessive inflammation and hypersecretion of mucus 
secondary to smoking tobacco products.3,26 Analysis of the 
COPDGene cohort showed that slightly more than one quar-
ter of COPD subjects reported chronic bronchitis.27 There 
was also a twofold increase in risk of chronic bronchitis in 
current smokers in the COPDGene study. In contrast, more 
than one-third of our study respondents reported a frequent 
productive cough, perhaps reflecting causes of chronic cough 
other than COPD. Notably, there was less of a difference in 
the frequency of dyspnea between current vs former smok-
ers; we speculate that dyspnea may be an important reason 
for smoking cessation in some cases.
Chronic productive cough also increased with smoking 
duration among smokers with no evidence of COPD in the 
current study. A study that evaluated the relationship among 
respiratory symptoms, COPD, and airflow for over 30 years 
found that 40% of smokers developed chronic bronchitis and 
half of those developed COPD.28 In the Seven Countries Study, 
among continuous smokers without chronic bronchitis or any 
other pulmonary disease, those with a smoking history of 
20–40 pack-years (P=0.001) or .40 pack-years (P=0.002) had 
lower mean FEV
0.75
 than those with a smoking history of ,20 
pack-years.28 Furthermore, of smokers with no airflow obstruc-
tion in the COPDGene study, those with chronic bronchitis had 
a greater pack-year smoking history and were more likely to 
be current smokers than those without chronic bronchitis.29 In 
that study, non-obstructive chronic bronchitis was defined by 
a history of cough and phlegm production for $3 consecu-
tive months per year, and its results suggest that bronchitic 
symptoms such as productive cough in the absence of airflow 
obstruction could be an early marker of susceptibility and 
risk for COPD.29–31 Unfortunately, COPD in the current study 
was defined by having emphysema, chronic bronchitis, and/or 
COPD, so that those subgroups cannot be determined.
Little information has been available in US populations to 
address the relationship between smoking duration, COPD, 
and respiratory symptoms, so this study is unique. How-
ever, our study had several limitations. First, the BRFSS is 
a cross-sectional study of the South Carolina population, so 
causal relationships between smoking duration, COPD, 
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and respiratory symptoms cannot be established. Second, 
the study response rate was less than 50% and selection 
bias might influence our results if participation varied by 
smoking duration. Third, the analyses relied on self-reported 
information from a telephone interview about current smok-
ing, smoking duration, respiratory symptoms, and COPD, 
and cannot be validated. However, previous studies support 
that a self-report of provider-diagnosed COPD is highly 
reliable,18,32 although undiagnosed COPD may affect our 
results.33–35 Validity may also differ between self-reported 
emphysema and self-reported chronic bronchitis.36
While 76.4% of subjects with self-reported COPD also 
reported having had a breathing test in our study, there is no 
information regarding test interpretation. However, having 
had a breathing test did not differ by smoking status among 
those with COPD. This finding is comparable with that of a 
larger 2011 US survey of approximately 13,000 adults with 
self-reported COPD, in which the percentage of subjects hav-
ing had a breathing test to diagnose COPD did not differ by 
smoking status.37 Furthermore, use of smoking duration and 
current smoking status give only partial information about 
tobacco use. Other useful information for such a study could 
include intensity (number or packs smoked per day), pack-years 
(a product of intensity and duration), age at initiation, and time 
since cessation, but such information cannot be obtained during 
a time-limited interview.19 However, our results are consistent 
with findings for pack-years of smoking that have been applied 
in previous studies.5–7 In addition, using smoking duration rather 
than pack-years or additional smoking indicators that employ 
a time factor in the same analytic models may have helped to 
reduce multicollinearity and avoid a cohort effect.19
The US Preventive Services Task Force so far has found 
no evidence to support screening adults (including asymp-
tomatic smokers) for COPD using spirometry.38 However, 
the recommendations do suggest that current smokers should 
receive smoking cessation counseling and pharmacologic 
therapies that have been demonstrated to increase cessation 
rates. Smoking cessation may improve respiratory symptoms 
and bronchial hyperresponsiveness and prevent excessive 
decline in lung function among smokers with COPD as well 
as among smokers without chronic symptoms.21 Smokers 
with respiratory symptoms, including dyspnea and productive 
cough, may be more susceptible to the effects of smoking 
on rate of decline in FEV
1
 than those without symptoms, 
thus representing an important target group for smoking 
cessation interventions.14 The United States Public Health 
Service guidelines recommend a simple intervention of “5 
As”, ie, “ask about tobacco use”, “advise to quit”, “assess 
willingness to make a cessation attempt”, “assist in cessation 
attempt”, and “arrange follow-up” to make prevention and 
cessation of tobacco use more successful.39 Therefore, there 
are opportunities for physicians to provide tobacco cessa-
tion counseling to all patients who smoke, particularly those 
with respiratory symptoms and/or COPD. Such efforts will 
have the largest impact on decreasing COPD in men and 
women alike.
Conclusion
In this population-based survey of adults with a smoking his-
tory, prolonged tobacco use was associated with an increased 
likelihood of having COPD, frequent productive cough, 
frequent SOB, and agreement that SOB affected physical 
activity even after controlling for current smoking behavior. 
Former smokers who had quit smoking for $10 years had a 
lower prevalence of COPD and respiratory symptoms than 
current smokers. The prevalence of COPD was higher in 
women than in men at all levels of smoking duration. This 
study also demonstrates that the BRFSS is a useful surveil-
lance tool to describe the association of potential risk factors 
for COPD and respiratory symptoms in an adult state popu-
lation and could be expanded to other US states for public 
health surveillance purposes.
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